GLP-1 drugs achieve some of these effects by directly affecting the brain’s cravings for food, and that might also extend to ...

Patients taking liraglutide or semaglutide for weight loss report their alcohol intake dropping with the pounds-by as much as ...

The first clinical trial comparing semaglutide and tirzepatide, two popular, injectable weight-loss drugs, has been published ...

A head-to-head trial found that tirzepatide led to significantly greater weight loss and waist reduction than semaglutide in ...

Tirzepatide slashed weight by 20%, leading researchers to call this a new “golden age” for weight-loss therapies.

The weight-loss drug Wegovy slashes the risk of heart disease even before people shed many pounds, data suggests.The drug, which contains the active ingredient semaglutide, works by reducing food ...

While GLP-1 receptor agonists and bariatric surgery offer significant metabolic benefits, experts caution that rapid weight ...

Participants who took tirzepatide — which is sold as Zepbound by Eli Lilly — lost an average of 50 pounds over 72 weeks.

In the first direct comparison study involving individuals with obesity, tirzepatide demonstrated approximately 50% greater ...

Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, ...

While the primary target for these medication is weight loss, it’s not the only metric by which the drugs should be evaluated ...

SynergenX, a leading provider of hormone therapy and wellness services, is partnering with Low T Center to launch a new ...